Dupixent and ACCIDENTAL EXPOSURE TO PRODUCT

13,305 reports of this reaction

1.6% of all Dupixent reports

#14 most reported adverse reaction

Overview

ACCIDENTAL EXPOSURE TO PRODUCT is the #14 most commonly reported adverse reaction for Dupixent, manufactured by Sanofi-Aventis U.S. LLC. There are 13,305 FDA adverse event reports linking Dupixent to ACCIDENTAL EXPOSURE TO PRODUCT. This represents approximately 1.6% of all 838,442 adverse event reports for this drug.

Patients taking Dupixent who experience accidental exposure to product should discuss this symptom with their healthcare provider to determine whether it may be related to their medication and what alternatives may be available.

Reporting Frequency

ACCIDENTAL EXPOSURE TO PRODUCT13,305 of 838,442 reports

ACCIDENTAL EXPOSURE TO PRODUCT is a less commonly reported adverse event for Dupixent, but still significant enough to appear in the safety profile.

Other Side Effects of Dupixent

In addition to accidental exposure to product, the following adverse reactions have been reported for Dupixent:

PRURITUS — 52,379 reports
DERMATITIS ATOPIC — 41,045 reports
PRODUCT USE IN UNAPPROVED INDICATION — 38,078 reports
RASH — 35,570 reports
INJECTION SITE PAIN — 32,857 reports
DRUG INEFFECTIVE — 27,750 reports
ECZEMA — 24,172 reports
PRODUCT DOSE OMISSION ISSUE — 23,332 reports
DRY SKIN — 23,316 reports
CONDITION AGGRAVATED — 19,621 reports

Other Drugs Associated with ACCIDENTAL EXPOSURE TO PRODUCT

The following drugs have also been linked to accidental exposure to product in FDA adverse event reports:

ACETAMINOPHEN, CHLORPHENIRAMINE MALEATE, DEXTROMETHORPHAN HYDROBROMIDE, AND PHENYLEPHRINE HYDROCHLORIDE AMMONIA N 13 AVOBENZONE 3%, HOMOSALATE 15%, OCTISALATE 5%, OCTOCRYLENE 10%BELIMUMAB BLINATUMOMAB CAMPHOR AND MENTHOL CHLORHEXIDINE GLUCONATE 4%DUPILUMAB ERENUMAB AOOE EVOLOCUMAB FREMANEZUMAB VFRM GUSELKUMAB HISTAMINE DIHYDROCHLORIDE MICONAZOLE NITRATE 2%NEOMYCIN SULFATE, POLYMYXIN B SULFATE AND HYDROCORTISONE NITROGEN NYSTATIN AND TRIAMCINOLONE ACETONIDE PEGFILGRASTIM POTASSIUM NITRATE Repatha

Frequently Asked Questions

Does Dupixent cause ACCIDENTAL EXPOSURE TO PRODUCT?

ACCIDENTAL EXPOSURE TO PRODUCT has been reported as an adverse event in 13,305 FDA reports for Dupixent. This does not prove causation, but indicates an association observed in post-market surveillance data.

How common is ACCIDENTAL EXPOSURE TO PRODUCT with Dupixent?

ACCIDENTAL EXPOSURE TO PRODUCT accounts for approximately 1.6% of all adverse event reports for Dupixent, making it a notable side effect.

What should I do if I experience ACCIDENTAL EXPOSURE TO PRODUCT while taking Dupixent?

If you experience accidental exposure to product while taking Dupixent, contact your healthcare provider. They can evaluate whether the symptom is related to your medication and discuss potential adjustments to your treatment plan. Do not stop taking prescribed medication without consulting your doctor.

Dupixent Full Profile All Drugs Causing ACCIDENTAL EXPOSURE TO PRODUCT Sanofi-Aventis U.S. LLC Drugs

Disclaimer: This analysis is based on FDA adverse event reports and is for informational purposes only. Reports do not prove causation. Always consult your healthcare provider.